Michael Maschek, DPM
Foot & Ankle Surgery · Opp, ALNPI 1982624433
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,325 of the $4,357 with a category attached, or 76.3%. 9 manufacturers reported payments, led by Medical Device Business Services, Inc. at 30.3% of the total. That places this record below the midpoint for foot & ankle surgery clinicians in AL, where the typical reported total is $4,589.
Across 40 payments — averaging $108.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Medtronic$1K
- Solventum Corporation$913
- Biotissue Holdings Inc.$874
- Johnson & Johnson$169
- Ossur Americas, Inc.$28
- plus $50 from 3 others
What the payments were for
- Travel & lodging$3,32576%
- Food & beverage$1,03224%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $1,318 |
| Medtronic | 6 | $1,006 |
| Solventum Corporation | 8 | $913 |
| Biotissue Holdings Inc. | 6 | $874 |
| Johnson & Johnson | 6 | $169 |
| Ossur Americas, Inc. | 1 | $28 |
| Kerecis Limited | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$869
- PREVENA$823
- V.A.C. VERAFLO$524
How this compares
$4,357 in reported general payments places this provider in the 45th percentile of 40 foot & ankle surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 174 | $3,560 |
| Pregabalin | 129 | $3,325 |
| Terbinafine Hcl | 134 | $2,469 |
| Itraconazole | 15 | $2,262 |
| Linezolid | 20 | $1,323 |
| Cilostazol | 56 | $1,064 |
| Ammonium Lactate | 33 | $1,000 |
| Lidocaine | 13 | $644 |
| Celecoxib | 19 | $613 |
| Doxycycline Hyclate | 43 | $437 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $430 |
| Levofloxacin | 86 | $331 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $324 |
| Mupirocin | 11 | $198 |
| Tramadol Hcl | 23 | $138 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Opp
- Norman WaldropBirmingham$3.6M
- Justin DaigreDecatur$372K
- John KirchnerHoover$84K
- Jefferson SabatiniHuntsville$56K
- Matthew DeorioHuntsville$49K
- Patricia AnteroTuscaloosa$35K
- Ashish ShahBirmingham$28K
- Alfred RicciMontgomery$25K
- Swapnil SinghBirmingham$14K
- Derek KlavasMobile$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.